← Back to Patent Explorer
US4396607A Expired / Lapsed US ⏱️ 0.0 years remaining

Muramyl peptide derivatives and pharmaceutical compositions

Assignee: Bpifrance Financement SA
•
Filing: 1981-05-01
•
Granted: 1983-08-02
•
Expires: 2001-05-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention relates to new compounds useful notably as regulator of immune responses and which are derivatives of muramyl peptides substituted at the end of the peptide chain by a group containing at least four carbon atoms.

Inventors

  • 👤 Pierre LeFrancier
  • 👤 Monique Parant
  • 👤 Francoise Audibert
  • 👤 Edgar Sache
  • 👤 Louis Chedid
  • 👤 Jean Choay
  • 👤 Edgar Lederer

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 15:55
CPC Classifications
C; C07; C07K; C07K9/00; C07K9/001; C07K9/005; A; A61; A61K; A61K9/00; A61K9/10; A61K9/127; A61K9/1271

Claims Analysis

Total Claims: 51
Claim 1
Independent Claim 273 words
A compound which is an immunological adjuvant and effective against Klebsiella, which compound has the formula: ##STR18## in which the substituents R, R 1 , R 2 , R 4 , R 6 , X, Y and Z has the following definition: R is hydrogen or an alkyl group having 1 to 4 carbon atoms, R 1 is hydrogen hydroxyl or phenylamino, R 2 is hydrogen or methyl, R 4 is hydrogen or acyl group having 1 to 4 carbon atoms, R 6 is hydrogen, saturated or unsaturated acyl having from 1 to about 4 carbon atoms, mycolyl group having 80 to 90 carbon atoms or corynomycoyl, X is L-alanyl, L-seryl, L-valyl, or glycyl, Y is -OH, an alkoxy radical having from 1 to 10 carbon atoms, or -NH 2 , the hydrogens of the amino group being optionally substituted by alkyl residues having 1 to 10 carbon atoms, or an aminoacyl residue, A is an aminoacyl residue selected from the group consisting of L-alanyl, L-arginyl, L-asparagyl, L-aspartyl, L-cystenyl, L-glutaminyl, L-glutamyl, glycyl, L-histidyl, L-hydroxyprolyl, L-isoleucyl, L-leucyl, L-lysyl, L-methionyl, L-orinthyl, L-phenylalanyl, L-prolyl, L-seryl, L-threonyl, L-tryptophanyl, L-tyrosyl and L-valyl or an aminoalcohol residue (-NH-CH-CH 2 -O-) corresponding to these aminoacyls (-NH-CH-CO-), wherein when the A groups are present in the same compound they may be identical or different, n is zero or 1, Z is selected from the group consisting of -OR', -NHR', -OCH 2 -CH 2 O-COR' or -OCH 2 -CHOH-CH 2 O-R°, wherein R° is a mycolic acid group having from 80 to 90 carbon atoms, or corynomycoyl and R' is a linear or branched alkyl group having 4 to 20 carbon atoms.
Claim 2
Dependent Claim 273 words
A compound which is an immunological adjuvant and effective against Klebsiella, which compound has the formula: ##STR18## in which the substituents R, R 1 , R 2 , R 4 , R 6 , X, Y and Z has the following definition: R is hydrogen or an alkyl group having 1 to 4 carbon atoms, R 1 is hydrogen hydroxyl or phenylamino, R 2 is hydrogen or methyl, R 4 is hydrogen or acyl group having 1 to 4 carbon atoms, R 6 is hydrogen, saturated or unsaturated acyl having from 1 to about 4 carbon atoms, mycolyl group having 80 to 90 carbon atoms or corynomycoyl, X is L-alanyl, L-seryl, L-valyl, or glycyl, Y is -OH, an alkoxy radical having from 1 to 10 carbon atoms, or -NH 2 , the hydrogens of the amino group being optionally substituted by alkyl residues having 1 to 10 carbon atoms, or an aminoacyl residue, A is an aminoacyl residue selected from the group consisting of L-alanyl, L-arginyl, L-asparagyl, L-aspartyl, L-cystenyl, L-glutaminyl, L-glutamyl, glycyl, L-histidyl, L-hydroxyprolyl, L-isoleucyl, L-leucyl, L-lysyl, L-methionyl, L-orinthyl, L-phenylalanyl, L-prolyl, L-seryl, L-threonyl, L-tryptophanyl, L-tyrosyl and L-valyl or an aminoalcohol residue (-NH-CH-CH 2 -O-) corresponding to these aminoacyls (-NH-CH-CO-), wherein when the A groups are present in the same compound they may be identical or different, n is zero or 1, Z is selected from the group consisting of -OR', -NHR', -OCH 2 -CH 2 O-COR' or -OCH 2 -CHOH-CH 2 O-R°, wherein R° is a mycolic acid group having from 80 to 90 carbon atoms, or corynomycoyl and R' is a linear or branched alkyl group having 4 to 20 carbon atoms.
Claim 3
Dependent Claim 12 words
The compound according to claim 1, wherein X is the L-alanyl residue.
Claim 4
Dependent Claim 30 words
The compound according to claim 1 wherein Z is -OCH 2 -CHOH-CH 2 O-R°, wherein R°, is a mycolic acid group having from 80 to 90 carbon atoms or corynomycolyl.
Claim 5
Dependent Claim 10 words
The compound according to claim 1, wherein A is L-alanyl.
Claim 6
Dependent Claim 10 words
The compound according to claim 1, wherein Y is -OH.
Claim 7
Dependent Claim 12 words
The compound according to claim 1, wherein Y is -OCH 3 .
Claim 8
Dependent Claim 14 words
The compound according to claim 1, wherein Y is -OC 4 H 9 .
Claim 9
Dependent Claim 12 words
The compound according to claim 1, wherein Y is -NH 2 .
Claim 10
Dependent Claim 10 words
The compound according to claim 1, wherein R is hydrogen.
Claim 11
Dependent Claim 12 words
The compound according to claim 1, wherein R is -CH 3 .
Claim 12
Dependent Claim 17 words
The compound according to claim 1, wherein R 1 , R 4 and R 6 are hydrogen.
Claim 13
Dependent Claim 23 words
The compound according to claim 1, wherein R 1 , R 6 is selected from the group consisting of hydrogen, acetyl and succinyl.
Claim 14
Dependent Claim 11 words
The compound according to claim 12, wherein R 6 is hydrogen.
Claim 15
Dependent Claim 10 words
The compound according to claim 13 wherein A is L-alanyl.
Claim 16
Dependent Claim 10 words
The compound according to claim 14 wherein Y is amine.
Claim 17
Dependent Claim 17 words
The compound according to claim 1, wherein R 6 is acyl of 1 to 4 carbon atoms.
Claim 18
Dependent Claim 18 words
The compound according to claim 1 wherein R' is an alkyl group having 15 to 20 carbon atoms.
Claim 19
Dependent Claim 66 words
A compound which has anti-Listeria activity, which compound has the formula ##STR19## wherein Y is selected from the group consisting of hydroxy, amino and alkoxy of 1 to 10 carbon atoms, and R 1 is a linear or branched alkyl group having 4 to 20 carbon atoms or -OCH 2 -OCHOH-CH 2 O-R°, wherein R° a mycolic acid group having from 80 to 90 carbon atoms.
Claim 20
Dependent Claim 66 words
A compound which has anti-Listeria activity, which compound has the formula ##STR19## wherein Y is selected from the group consisting of hydroxy, amino and alkoxy of 1 to 10 carbon atoms, and R 1 is a linear or branched alkyl group having 4 to 20 carbon atoms or -OCH 2 -OCHOH-CH 2 O-R°, wherein R° a mycolic acid group having from 80 to 90 carbon atoms.
Claim 21
Dependent Claim 15 words
The compound of claim 18 wherein R' is alkyl of 4 to 10 carbon atoms.
Claim 22
Dependent Claim 16 words
The compound of claim 18 wherein Y is an alkoxy of 3 to 5 carbon atoms.
Claim 23
Dependent Claim 13 words
The compound of claim 18 wherein Y is butoxy and R' is decyl.
Claim 24
Dependent Claim 16 words
The compound of claim 18 wherein Y is amino, n is 0 and R' is butyl.
Claim 25
Dependent Claim 16 words
The compound of claim 18 wherein Y is amino, n is 1 and R' is butyl.
Claim 26
Dependent Claim 17 words
The compound of claim 18 wherein Y is propoxy, n is 0 and R 1 is butyl.
Claim 27
Dependent Claim 16 words
The compound of claim 18 wherein Y is propoxy, n is 1 and R' is butyl.
Claim 28
Dependent Claim 16 words
The compound of claim 18 wherein Y is pentoxy, n is 0 and R' is butyl.
Claim 29
Dependent Claim 16 words
The compound of claim 18 wherein Y is pentoxy, n is 1 and R is butyl.
Claim 30
Dependent Claim 33 words
The compound of claim 18 wherein Y is amino, n is 0 and R' is -OCH 2 -CHOH-CH 2 O-R°, wherein R° is a mycolic acid group having 80 to 90 carbon atoms.
Claim 31
Dependent Claim 16 words
The compound of claim 18 wherein Y is ethoxy, n is zero and R is decyl.
Claim 32
Dependent Claim 30 words
A pharmaceutical composition for stimulating the immune response in warm-blooded animals, which comprises a biologically acceptable carrier and an effective dose of at least one effective compound of claim 1.
Claim 33
Dependent Claim 18 words
The pharmaceutical composition according to claim 30, wherein the lipid portion of the liposomes have a lipid portion.
Claim 34
Dependent Claim 19 words
The pharmaceutical composition according to claim 31 wherein the lipid portion of the liposomes is constituted by a phospholipid.
Claim 35
Dependent Claim 12 words
The pharmaceutical composition according to claim 32 wherein the compound is N-acetyl-muramyl-L-alanyl-D-isoglutaminyl-L-alanyl-D-glyceryl-mycolate.
Claim 36
Dependent Claim 20 words
The pharmaceutical composition according to claim 30 wherein the aqueous phase is buffered to a pH at or near neutrality.
Claim 37
Dependent Claim 24 words
The pharmaceutical composition according to claim 30, wherein the injectable medium is constituted by an aqueous injectable isotonic and sterile saline or glucose solution.
Claim 38
Dependent Claim 16 words
The pharmaceutical composition according to claim 30, wherein the active compound is suitable for oral administration.
Claim 39
Dependent Claim 13 words
The pharmaceutical composition according to claim 36 wherein the compound is N-acetyl-muramyl-1-alanyl-D-isoglutaminyl-L-alanyl-butyl ester.
Claim 40
Dependent Claim 13 words
The pharmaceutical composition according to claim 36 wherein the compound is N-acetyl-muranyl-L-alanyl-D-isoglutaminyl-butyl ester.
Claim 41
Dependent Claim 29 words
The pharmaceutical composition according to claim 30 for anti-infectious treatment and parenteral administration, in the form of unit doses containing from 10 to 20,000 mg of the effective compound.
Claim 42
Dependent Claim 42 words
A biological composition for stimulating in a warm-blooded animal an immune response against Listeria comprising a biologically acceptable carrier and an effective dose of at least one compound of claim 18, 19, 20, 21, 22, 23, 24, 25, 27, 28 or 29.
Claim 43
Dependent Claim 37 words
A method for modifying the immune responses of a warm blooded animal comprising administering to said warm-blooded animal a composition comprising a biologically acceptable carrier and an effective amount of at least one compound of claim 1.
Claim 44
Dependent Claim 12 words
The method according to claim 41 wherein the compound is administered orally.
Claim 45
Dependent Claim 25 words
A method for treating infectious diseases in warm-blooded animals comprising administering an effective amount of at least one compound of claim 1 to said animal.
Claim 46
Dependent Claim 13 words
The method according to claim 43 wherein the compound administered is N-acetyl-muramyl-alanyl-D-isoglutaminyl-L-alanyl-butyl ester.
Claim 47
Dependent Claim 12 words
The method according to claim 43 wherein the compound is N-acetyl-muranyl-L-alanyl-D-isoglutaminyl-butyl ester.
Claim 48
Dependent Claim 96 words
A method of stimulating an immune response in a warm-blooded animal against Listeria which comprises administering to said animal a composition comprising a biologically acceptable carrier and an effective amount of at least one compound of the formula of claim 18, wherein Y is selected from the group consisting of hydroxy, amino and alkoxy of 1 to 10 carbon atoms, and R 1 is a linear or branched alkyl group having 4 to 20 carbon atoms or -OCH 2 -CHOH-CH 2 O-R°, wherein R° is a mycolic acid group having from 80 to 90 carbon atoms.
Claim 49
Dependent Claim 22 words
The method of claim 46 wherein the compound is N-acetyl-muramyl-L-alanyl-D-isoglutaminyl-L-acyl-D-glyceryl-mycolate, wherein the mycolic acid radical contains from 80 to 90 carbon atoms.
Claim 50
Dependent Claim 11 words
The method of claim 47 wherein the compound is N-acetyl-murmyl-L-alanyl-D-isoglutaminyl-butyl ester.
Claim 51
Dependent Claim 34 words
A method for producing a delayed type hypersensitivity reaction to antigens in warm-blooded animals which comprises administering to said animal an effective amount of the compound of claim 18 and a biologically acceptable carrier.

References Cited (Backward Citations)

DE3833C Cited
GB201534A Cited
US4153684A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-08-01 1987-01-31 1987-08-02 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-08-01 1991-01-31 1991-08-02 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-08-01 1995-01-31 1995-08-02 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag